Brauchen wir die Grippemittel Tamiflu und Relenza?

Lately, several press releases as well as a parliamentary inquiry questioned the effectiveness of the neuraminidase inhibitors (NAI, oseltamivir and zanamivir) in concerns of therapy of influenza. However, in combination with the unfortunate data communication by the pharma industry after the latest...

Full description

Bibliographic Details
Main Authors: Schmidtke, Michaela, Mertens, Thomas, Gesellschaft für Virologie e.V. (GfV), Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten e.V. (DVV), Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG)
Format: Article
Language:English
Published: German Medical Science GMS Publishing House 2014-08-01
Series:GMS Infectious Diseases
Online Access:http://www.egms.de/static/en/journals/id/2014-2/id000014.shtml